Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Stomach Neoplasms × enzalutamide × Clear all

Sponsor

Conditions

Prostatic Neoplasms 59 Breast Neoplasms 9 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 6 Neoplasms 4 Prostate Cancer Metastatic 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Metastatic Castration-resistant Prostate Cancer 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Metastatic Hormone Sensitive Prostate Cancer 2 Metastatic Castration Resistant Prostate Cancer 2 Melanoma 2 mCRPC 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ureteral Diseases 1 Small Cell Lung Carcinoma 1 Seizures 1 Salivary Cancer 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Pancreatic Neoplasms 1 Neoplasms, Squamous Cell 1 Metastatic Progressive Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castrate-Resistant Prostate Cancer 1 Mesothelioma 1 Lymphoma, Mantle-Cell 1

Interventions

Oxaliplatin 47 Cisplatin 43 Fluorouracil 42 Capecitabine 41 pembrolizumab 31 Leucovorin 28 Docetaxel 22 Irinotecan 19 Paclitaxel 18 Trastuzumab 17 Bevacizumab 12 Ramucirumab 11 Cetuximab 9 Radiotherapy 8 Surgical Procedures, Operative 7 Nivolumab 7 S 1 (combination) 6 Epirubicin 6 Carboplatin 6 Sunitinib 4 Platinum 4 Mitomycin 4 trastuzumab deruxtecan 3 olaparib 3 epacadostat 3 bemarituzumab 3 Pemetrexed 3 Ipilimumab 3 Folfox protocol 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡